Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
26 hedge funds and large institutions have $33.3M invested in Celgene Corporation Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
CELGZ Hedge Fund Activity: Q2 2013 in Review
26 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2013, worth a combined $33.3M.
Buyers outnumbered sellers: 26 funds opened new CELGZ positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
- 26 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $33.3M of Celgene Corporation Contingent Value Rights stock for Q2 2013.
- 26 funds opened new Celgene Corporation Contingent Value Rights positions in Q2 2013 and 0 closed out, a net change of +26 holders.
Based on aggregated 13F filings for Q2 2013.